During the International Conference on Antimicrobial Resistance and Infectious Diseases, the Sub-Committee on Antimicrobial Resistance Highlights Bahrain’s National Health Experience
26/09/2026
As part of the Kingdom of Bahrain’s efforts to strengthen its health security system and address antimicrobial resistance (AMR), the Sub-Committee on Antimicrobial Resistance participated in the fourth edition of the International Conference on Antimicrobial Resistance and Infectious Diseases, hosted by the Kingdom of Bahrain from 24 to 25 September.
During a panel discussion, members of the Sub-Committee reviewed the latest developments and advancements in the field of antimicrobial resistance, with the participation of a distinguished group of experts and specialists from the Kingdom of Bahrain, the Gulf Cooperation Council (GCC) countries, and a number of countries across the region.
The session addressed several strategic areas, most notably the impact of effective interventions in reducing antimicrobial resistance, the role of governance and health leadership in supporting antimicrobial stewardship programmes, as well as developing specialized health professionals and workforce capacities. The discussion also highlighted the use of data, digital technologies, and artificial intelligence to support decision-making processes.
The participants emphasized the importance of continuing to expand the implementation of antimicrobial stewardship policies across relevant sectors, strengthening specialized training and capacity-building programmes, and broadening the participation of various medical disciplines in these programmes. These efforts contribute to the sustainability of national initiatives to address antimicrobial resistance.
During the session, participants presented a number of national experiences and practices that have demonstrated effectiveness, while also discussing the challenges associated with translating national policies into practical practices and applications at the level of healthcare institutions.
The discussions concluded by emphasizing the importance of continuing to strengthen regional cooperation and developing sustainable national programmes, contributing to enhancing patient safety, preserving the effectiveness of antimicrobials for future generations, and supporting the development of a more resilient health system capable of addressing global health challenges.
During a panel discussion, members of the Sub-Committee reviewed the latest developments and advancements in the field of antimicrobial resistance, with the participation of a distinguished group of experts and specialists from the Kingdom of Bahrain, the Gulf Cooperation Council (GCC) countries, and a number of countries across the region.
The session addressed several strategic areas, most notably the impact of effective interventions in reducing antimicrobial resistance, the role of governance and health leadership in supporting antimicrobial stewardship programmes, as well as developing specialized health professionals and workforce capacities. The discussion also highlighted the use of data, digital technologies, and artificial intelligence to support decision-making processes.
The participants emphasized the importance of continuing to expand the implementation of antimicrobial stewardship policies across relevant sectors, strengthening specialized training and capacity-building programmes, and broadening the participation of various medical disciplines in these programmes. These efforts contribute to the sustainability of national initiatives to address antimicrobial resistance.
During the session, participants presented a number of national experiences and practices that have demonstrated effectiveness, while also discussing the challenges associated with translating national policies into practical practices and applications at the level of healthcare institutions.
The discussions concluded by emphasizing the importance of continuing to strengthen regional cooperation and developing sustainable national programmes, contributing to enhancing patient safety, preserving the effectiveness of antimicrobials for future generations, and supporting the development of a more resilient health system capable of addressing global health challenges.
Comments
Currently there are no comments.
Login to add comment
